Anecdotal evidence lends credence to previous studies that marijuana is a viable treatment for the disorders
Crohn’s disease is a chronic disease that causes inflammation and irritation of the digestive tract. Symptoms can include cramping, constant pain and diarrhea, as well as resulting in severe weight loss. It is part of a group of diseases referred to as inflammatory bowel disease (IBD) and is usually treated with laboratory chemicals. However, new evidence supports the use of cannabis in treating the disease.
A recent study conducted by the University of Bath indicated that marijuana can exert certain effects to combat Crohn’s by adjusting the microbial balance in the gut. This can lead to a reduction in inflammation, as well as relieving pain. As an additional benefit, marijuana has already been prescribed to those patients who need to increase their appetite, which can counter the weight loss associated with Crohn’s. Investigations are still continuing, but the results have been very positive.
There have been even fewer studies conducted on bipolar disorder and the role marijuana might play in treating it; however, a few studies now suggest that some of the symptoms associated with the disorder – including activity and energy levels, mood swings and some routine daily functions – can be countered by the introduction of marijuana as treatment.
The debate lingers on, though, as analysis from several studies has shown mixed results. Several studies have shown positive reactions, but one, which was conducted on adolescents, had the opposite effect and increased certain symptoms.
